
Magenta Therapeutics
A biotechnology company developing therapeutics that unlock the power of stem cell biology.
Market cap
$42.4m
Enterprise value
($35m)
Share price
$18.63 MGTA
Authorizing premium user...
A biotechnology company developing therapeutics that unlock the power of stem cell biology.